Kanabo Group’s (KNB) CBD products are now available for sale via a leading UK eCommerce site dedicated to CBD, HandpickedCBD.com.
[Source; HandpickedCBD.com]
HandpickedCBD is one of the largest online CBD marketplaces in the UK listing over 50 brands and more than 500 products from oils, edibles, drinks, topicals, vapes and capsules that all meet strict safety and quality criteria.
In addition to officially launching sales in the UK, having the Company’s products listed on one of the leading online marketplaces in their product lineup for 2021 provides a level of credibility difficult to attain as a standalone CBD producer.
The three new proprietary formulas for delivery via Kanabo's VapePod, a patented and medical grade vaporiser with metered dosing, are now offered on Handpicked CBD:
Reload - Feels like a moment of clarity & focus. Formulated with stimulating peppermint and warm spice aromas from hemp derived terpenes, and reap the benefits of pure distillate broad spectrum CBD hemp oil.
Relax - Quiet your mind & find tranquility. Formulated with calming melon and sage aromas from hemp derived terpenes, and reap the benefits of pure distillate CBD hemp oil.
Repair - Release the tension and regain your balance. Formulated with rosemary and berry aromas from hemp derived terpenes and pure distillate broad spectrum CBD hemp oil enriched with cannabigerol.
HandpickedDBD is wholly owned by Materia, Kanabo’s strategic target acquisition first announced on the 26 July 2021, and this agreement clearly demonstrates how both parties are already working together to bring Kanabo’s proprietary products to market and accelerate the path to commercial sales volumes.
Kanabo CEO, Avihu Tamir said; “We are delighted to offer our CBD wellness line through Handpicked CBD. Consumers now have access to the most potent yet non-intoxicating CBD formulas with only the highest quality of ingredients. Kanabo’s R&D team has created these fast-acting formulas with the health and wellness of consumers in mind.”
View From Vox
Clearly extremely positive news for Kanabo CBD products to be listed for sale in the UK for the first time AND on one of the leading ecommerce CBDsites in the space.
CBD is non-psychoactive and is an appealing option for those who are looking to improve their health and wellness. The biggest advantage of CBD is that it has no mind-altering effects of cannabis or the adverse effects of certain pharmaceutical prescription drugs such as opioids and opiates.
The fact Handpicked is a Materia asset should also give investors’ confidence the collaboration between the two companies is strong, which bodes well for the proposed merger of the two companies.
Shares in KAN have traded to highs of 24p over the past three months following news of the proposed merger with Materia. Whilst there is no guarantee this merger, which soul constitute a Reverse Take Over on Aim, will close, clearly confidence is rising that both companies wan to do the deal following this announcement.
Reasons to KNB
Kanabo Group Plc is an R&D company currently selling a range of THC-Free Retail CBD Products in the Primary Markets and is in the process of developing further Medical Cannabis Products. The company’s core strategy is to increase revenues from the sale of its Retail CBD Products in the wellness sector and to grow the Kanabo brand through its marketing initiatives.
Following the completion of the Materia acquisition, Kanabo will own and operate a fully licensed pathway into the most lucrative medicinal and recreational cannabis markets in the World, including Germany, which was recently valued at over €200m per year, and is anticipated to remain the dominant market as the European market grows to a forecasted total size of €3.2bn by 2025 (Source; Prohibition Partners).
Whilst there remains some execution risk associated with the transaction and Reverse Takover under LSE rules, the potential for Kanabo to become one of the leading companies in this exciting space remains high.